Laser Therapy of Benign Thyroid Nodules
Maneno muhimu
Kikemikali
Tarehe
Imethibitishwa Mwisho: | 02/28/2007 |
Iliyowasilishwa Kwanza: | 09/05/2005 |
Uandikishaji uliokadiriwa Uliwasilishwa: | 09/05/2005 |
Iliyotumwa Kwanza: | 09/07/2005 |
Sasisho la Mwisho Liliwasilishwa: | 03/25/2007 |
Sasisho la Mwisho Lilichapishwa: | 03/26/2007 |
Tarehe halisi ya kuanza kwa masomo: | 12/31/2000 |
Tarehe ya Kukamilisha Utafiti: | 02/28/2006 |
Hali au ugonjwa
Uingiliaji / matibabu
Procedure: Interstitial laser photocoagulation
Awamu
Vigezo vya Kustahiki
Zama zinazostahiki Kujifunza | 20 Years Kwa 20 Years |
Jinsia Inastahiki Kujifunza | All |
Hupokea Wajitolea wa Afya | Ndio |
Vigezo | Inclusion Criteria: - Patients with a solitary solid thyroid nodule confirmed by ultrasonography - Patients with a solitary cystadenoma (cystic part more than 2 mL) confirmed by ultrasonography - Patients with an autonomous functioning thyroid nodule. Exclusion Criteria: - No family history of thyroid cancer - Prior radiation towards the neck - Fine needle biopsy without valid diagnostic criteria for benign thyroid disease - Nodules larger than 4 cm (largest diameter) - Suspicion of malignancy - Increased serum calcitonin - Pregnancy or lactation - Alcohol, medicine or drug abuse - No safe contraception - Physical or psychic condition that hinders corporation |
Matokeo
Hatua za Matokeo ya Msingi
1. To evaluate the efficacy and feasibility repeated ILP treatments in a prospective randomised study where the nodule and thyroid volume are measured 1, 3, 6 and 12 months after the ILP. [undefined]
2. In the study of patients with a cystadenoma the measures will be done like wise, but also the recurrence of the cystic part will be measured. [undefined]
3. Patients with an autonomous functioning nodule measurements of thyroid function are performed 1,2, 3, 6, 9 and 12 months after the ILP or 131I therapy. [undefined]